ID Source | ID |
---|---|
PubMed CID | 6439164 |
MeSH ID | M0186658 |
Synonym |
---|
norvalyl-n(3)-(4-methoxyfumaroyl)-2,3-diaminopropionic acid |
[(2s)-2-amino-3-[[(e)-4-methoxy-4-oxobut-2-enoyl]amino]propanoyl] (2s)-2-aminopentanoate |
108340-69-8 |
l-alanine, 3-((4-methoxy-1,4-dioxo-2-butenyl)amino)-n-l-norvalyl-, (e)- |
nva fmdp |
[(2s)-2-amino-3-[[(e)-4-methoxy-4-oxo-but-2-enoyl]amino]propanoyl] (2s)-2-aminopentanoate |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (83.33) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.24) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |